Learn

Acid Reflux

Clinical Trials

Acid Reflux

It’s Not Just About The Acid.

What Causes It?
What Causes It?
How Re:flux Works
How Re:flux Works
Ingredients
Ingredients
30 Days to Re:lief
30 Days to Re:lief
30 Days to Re:set
30 Days to Re:set
Clinical Trials
Clinical Trials
FAQs
FAQs

THE SCIENCE OF REFLUX

Clinical Trial

Clinically Proven

Atrantil has been studied for its role in reducing gas, bloating, and digestive discomfort by targeting microbial imbalances in the gut.

Open Journal of Gastroenterology March 17, 2026

Retrospective Clinical Study (GERD)

A retrospective chart analysis published in the Open Journal of Gastroenterology evaluated a polyphenol-based nutraceutical (Re:flux) in patients with chronic GERD.

In this study:
• 81% of patients reported complete symptom resolution
• 91.5% of patients experienced clinically meaningful improvement (≥75%)
• All patients reporting bloating at baseline experienced improvement by week 479.3% of patients discontinued acid-suppressing medications

The study was published in: Open Journal of Gastroenterology March 17, 2026

Additional study details:
• Patients had confirmed chronic GERD via endoscopy
• Participants discontinued PPIs and H2 blockers prior to treatment
• Outcomes were measured over a 4-week period using structured symptom scoring
• Compared nutraceutical group (n=47) vs usual care (n=25)

View Clinical Trial